Amcor (AMCR) Q3 2026 earnings review
Synergies Mask Volume Rot, But Cash Flow Takes a Hit
One year into the Berry Global merger, Amcor is executing its synergy playbook flawlessly, delivering $77M in Q3 and keeping Adjusted EPS growing (+6% YoY to $0.96). However, the underlying engine is sputtering. Organic volumes fell another 1.5%, marking a continued pattern of demand weakness. The real shock came in the cash flow statement: management slashed FY26 Free Cash Flow guidance by $300M, citing the need to stockpile expensive inventory to navigate Middle East shipping disruptions. The Berry integration is successfully inflating margins in Rigid Packaging, but Amcor is now paying a steep working capital penalty for global supply chain fragility.
🐂 Bull Case
The Berry integration continues to track ahead of schedule. $77M in synergies were realized in Q3, pushing the FY26 expectation to $270M (up from 'at least $260M'). This self-help lever is effectively protecting EPS (+6%) from volume stagnation.
The addition of Berry's footprint has fundamentally improved the quality of the Rigid Packaging segment. Adjusted EBIT margin expanded by a massive 280 bps YoY to 10.4%, demonstrating immediate accretive value.
🐻 Bear Case
The FCF guidance cut from $1.85B (midpoint) to $1.55B is a significant blow to the deleveraging narrative. Holding higher, costlier inventory to offset geopolitical risks traps capital and delays target debt metrics.
A 1.5% volume decline shows that the core business remains unable to grow organically. With price/mix offering no material benefit, Amcor is entirely reliant on cost-cutting to drive earnings.
⚖️ Verdict: ⚪
Neutral. The Berry acquisition is doing exactly what it was supposed to do: buy time and synergies. However, a $300M cash flow hit and persistent negative volumes prevent a bullish stance until organic demand recovers.
Key Themes
Geopolitics Crush Cash Flow Guidance
Management was forced to abandon its $1.8-$1.9B Free Cash Flow target, revising it down to $1.5-$1.6B. The company had planned a ~$200M inventory reduction by year-end, but the Middle East conflict and Red Sea shipping constraints have forced them to hold higher inventory levels at higher costs to secure customer service. This is a severe working capital penalty that will delay debt paydown.
Rigid Packaging Transformation
The Berry Global integration is profoundly improving the Global Rigid Packaging Solutions segment. Sales surged 174% on a constant currency basis, largely driven by the acquisition. More importantly, Adjusted EBIT grew 273% CC, expanding the margin by 280 basis points to 10.4% from 7.6% a year ago. This segment has evolved from a laggard into a high-quality profit driver.
Volume Decay Remains Sticky
Amcor continues to suffer from stable but negative organic volume growth. Q3 volumes were down ~1.5% compared to the combined legacy Amcor/Berry businesses a year ago. Flexibles saw lower volumes in North America and Europe, offset slightly by Asia. Rigids saw lower volumes in healthcare and North America (exacerbated by US storm disruptions). Until this metric turns positive, top-line health is an illusion created by M&A.
Flexibles Margin Compression
While Rigids margin soared, the core Global Flexible Packaging Solutions segment saw its Adjusted EBIT margin slip from 14.3% to 13.9%. Despite $78M of acquired EBIT contributing to a 28% CC profit growth, underlying organic deleveraging from lower volumes in high-margin categories (healthcare) is placing pressure on the segment's profitability.
Other KPIs
Stable compared to $14.08B at the end of Q2, but remains a critical focal point given the massive debt assumed to close the Berry transaction. With FCF guidance slashed, the deleveraging timeline extends, keeping interest expenses elevated (Adjusted net interest was $150M in Q3, up $79M YoY).
Accelerating. Up from $55M in Q2 and $38M in Q1. The integration is executing at the upper end of expectations, driving the FY26 target to $270M (from 'at least $260M'). This is the single most important lever keeping the EPS growth story intact.
Guidance
Stable. Represents ~12% growth at the midpoint. YTD Adjusted EPS is $2.79, which implies Q4 Adjusted EPS needs to hit ~$1.21 to reach the midpoint. This implies an acceleration in Q4, heavily reliant on continued synergy realization and seasonal uplift.
Decelerating sharply. Slashed from $1.8-$1.9B. The company abandoned its planned ~$200M inventory reduction by year-end due to supply chain snarls linked to the Middle East. A harsh reminder of the working capital intensive nature of physical packaging.
Accelerating. The full-year target was slightly upgraded from 'at least $260 million', reflecting strong integration execution that is successfully offsetting volume softness.
Key Questions
Duration of Inventory Bloat
You slashed FCF guidance by $300M due to higher inventory holding requirements linked to the Middle East. Is this a permanent structural rebasing of your working capital needs, or do you expect this $300M to unwind into cash flow in FY27?
Flexibles Margin Compression
Flexibles Adjusted EBIT margin compressed by 40 bps YoY to 13.9%. How much of this is driven by mix shift (e.g., lower healthcare volumes) versus pure operational deleveraging from the 1.5% volume decline?
North American Beverage Divestiture
In prior quarters, you highlighted the $1.5B North American beverage business as a primary candidate for portfolio optimization. Does the current volume weakness and storm disruption impact the timeline or valuation expectations for exploring strategic alternatives?